This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Dyax Corporation, Human Genome Sciences, Inc.. Active years: 2006-2011.
Company Filing History:
Years Active: 2006-2011
Title: Innovations of James P Beltzer
Introduction
James P Beltzer is an accomplished inventor based in Carlisle, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of binding polypeptides related to B lymphocyte stimulator proteins. With a total of 3 patents, his work has implications for diagnosing and treating various diseases.
Latest Patents
One of his latest patents involves B-lymphocyte stimulator binding polypeptides and methods based thereon. This invention focuses on binding polypeptides that specifically target B lymphocyte stimulator protein or similar polypeptides. These binding polypeptides can be utilized in methods for detecting, diagnosing, or prognosing diseases associated with abnormal B lymphocyte stimulator expression or function. Another notable patent is for binding polypeptides for B lymphocyte stimulator protein (BLyS). This patent discloses specific amino acid sequences that bind to BLyS protein, which can be used for detecting or isolating BLyS protein in various biological samples.
Career Highlights
Throughout his career, James P Beltzer has worked with prominent companies in the biotechnology sector. He has been associated with Dyax Corporation and Human Genome Sciences, Inc., where he contributed to innovative research and development projects. His expertise in the field has allowed him to make impactful advancements in biotechnology.
Collaborations
James has collaborated with notable professionals in his field, including Tony J Fleming and M Daniel Potter. These collaborations have further enriched his research and development efforts.
Conclusion
James P Beltzer's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.